Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway

This study aimed to assess the effects of triterpene extract of Cyclocarya paliurus (Batal.) Iljinskaja (CPT) on diabetes-induced hepatic inflammation and to unveil the underlying mechanisms. Diabetes in db/db mice was alleviated after CPT administration, as assessed by the oral glucose tolerance te...

Full description

Bibliographic Details
Main Authors: Cuihua Jiang, Yiting Wang, Qiaomei Jin, Dongjian Zhang, Meng Gao, Nan Yao, Zhiqi Yin, Jian Zhang, Shiping Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00811/full
_version_ 1818144157205528576
author Cuihua Jiang
Cuihua Jiang
Cuihua Jiang
Yiting Wang
Qiaomei Jin
Qiaomei Jin
Dongjian Zhang
Dongjian Zhang
Meng Gao
Meng Gao
Nan Yao
Nan Yao
Zhiqi Yin
Jian Zhang
Jian Zhang
Shiping Ma
author_facet Cuihua Jiang
Cuihua Jiang
Cuihua Jiang
Yiting Wang
Qiaomei Jin
Qiaomei Jin
Dongjian Zhang
Dongjian Zhang
Meng Gao
Meng Gao
Nan Yao
Nan Yao
Zhiqi Yin
Jian Zhang
Jian Zhang
Shiping Ma
author_sort Cuihua Jiang
collection DOAJ
description This study aimed to assess the effects of triterpene extract of Cyclocarya paliurus (Batal.) Iljinskaja (CPT) on diabetes-induced hepatic inflammation and to unveil the underlying mechanisms. Diabetes in db/db mice was alleviated after CPT administration, as assessed by the oral glucose tolerance test. In addition, treatment with CPT dramatically reduced serum insulin, aspartate amino-transaminase, alanine aminotransferase, triglyceride, and total cholesterol amounts. Besides, serum levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α were also reduced after CPT administration. Western blot analysis revealed that CPT treatment significantly reversed the protein expression levels of Rho, ROCK1, ROCK2, p-P65, p-IκBα, p-IKKα, and p-IKKβ in liver samples obtained from db/db mice. Upon palmitic acid stimulation, the protective effects of CPT on the liver were further assessed in HepG2 and LO2 cells, and no appreciable cytotoxic effects were found. Therefore, these findings indicate that CPT alleviates liver inflammation via Rho-kinase signaling.Chemical compounds evaluated in this report: Metformin (PubChem CID: 4091); Fasudil (PubChem CID: 3547); Palmitic acid (PubChem CID: 985).
first_indexed 2024-12-11T11:43:06Z
format Article
id doaj.art-5179173b03f54408a1244bc34d3b7564
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T11:43:06Z
publishDate 2019-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-5179173b03f54408a1244bc34d3b75642022-12-22T01:08:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-07-011010.3389/fphar.2019.00811435482Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent PathwayCuihua Jiang0Cuihua Jiang1Cuihua Jiang2Yiting Wang3Qiaomei Jin4Qiaomei Jin5Dongjian Zhang6Dongjian Zhang7Meng Gao8Meng Gao9Nan Yao10Nan Yao11Zhiqi Yin12Jian Zhang13Jian Zhang14Shiping Ma15Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Province Academy of Traditional Chinese Medicine, Nanjing, ChinaDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Province Academy of Traditional Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Province Academy of Traditional Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Province Academy of Traditional Chinese Medicine, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Province Academy of Traditional Chinese Medicine, Nanjing, ChinaDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, ChinaAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Province Academy of Traditional Chinese Medicine, Nanjing, ChinaDepartment of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, ChinaThis study aimed to assess the effects of triterpene extract of Cyclocarya paliurus (Batal.) Iljinskaja (CPT) on diabetes-induced hepatic inflammation and to unveil the underlying mechanisms. Diabetes in db/db mice was alleviated after CPT administration, as assessed by the oral glucose tolerance test. In addition, treatment with CPT dramatically reduced serum insulin, aspartate amino-transaminase, alanine aminotransferase, triglyceride, and total cholesterol amounts. Besides, serum levels of interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α were also reduced after CPT administration. Western blot analysis revealed that CPT treatment significantly reversed the protein expression levels of Rho, ROCK1, ROCK2, p-P65, p-IκBα, p-IKKα, and p-IKKβ in liver samples obtained from db/db mice. Upon palmitic acid stimulation, the protective effects of CPT on the liver were further assessed in HepG2 and LO2 cells, and no appreciable cytotoxic effects were found. Therefore, these findings indicate that CPT alleviates liver inflammation via Rho-kinase signaling.Chemical compounds evaluated in this report: Metformin (PubChem CID: 4091); Fasudil (PubChem CID: 3547); Palmitic acid (PubChem CID: 985).https://www.frontiersin.org/article/10.3389/fphar.2019.00811/fullCyclocarya paliurustriterpenediabetes mellitushepatic inflammationROCKNF-κB
spellingShingle Cuihua Jiang
Cuihua Jiang
Cuihua Jiang
Yiting Wang
Qiaomei Jin
Qiaomei Jin
Dongjian Zhang
Dongjian Zhang
Meng Gao
Meng Gao
Nan Yao
Nan Yao
Zhiqi Yin
Jian Zhang
Jian Zhang
Shiping Ma
Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
Frontiers in Pharmacology
Cyclocarya paliurus
triterpene
diabetes mellitus
hepatic inflammation
ROCK
NF-κB
title Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
title_full Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
title_fullStr Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
title_full_unstemmed Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
title_short Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
title_sort cyclocarya paliurus triterpenoids improve diabetes induced hepatic inflammation via the rho kinase dependent pathway
topic Cyclocarya paliurus
triterpene
diabetes mellitus
hepatic inflammation
ROCK
NF-κB
url https://www.frontiersin.org/article/10.3389/fphar.2019.00811/full
work_keys_str_mv AT cuihuajiang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT cuihuajiang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT cuihuajiang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT yitingwang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT qiaomeijin cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT qiaomeijin cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT dongjianzhang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT dongjianzhang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT menggao cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT menggao cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT nanyao cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT nanyao cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT zhiqiyin cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT jianzhang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT jianzhang cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway
AT shipingma cyclocaryapaliurustriterpenoidsimprovediabetesinducedhepaticinflammationviatherhokinasedependentpathway